Remicade Information
Remicade Warning
Tuberculosis (frequently disseminated or extrapulmonary at clinical presentation), invasive fungal infections, and other opportunistic infections, have been observed in patients receiving REMICADE. Some of these infections have been fatal.
Patients should be evaluated for latent tuberculosis infection with a tuberculin skin test. Treatment of latent tuberculosis infection should be initiated prior to therapy with REMICADE.
Links to More Information
About Us
This website was developed for Remicade users to find information about Remicade issues such as the side effects, who’s at risk, etc.. Our goal is to inform you, the consumer, and connect you with legal help. To access our lawyers, please fill out the form here.
Relevant Resources
- Remicade Information - onlinelawyersource.com
- Remicade Cancer Risk - adrugrecall.com
- Cancer Consultants follows up on the Cancer risk story